
Cancer drug prices cut by up to 70% as NPPA caps margins
The story in brief
The National Pharmaceutical Pricing Authority (NPPA) capped trade margins for cancer drugs, reducing MRPs by up to 70% for some medicines. Patients can check revised prices on the NPPA website or app. The move aims to address high margins without disrupting existing pricing. Manoj Joshi, Pharma Secretary, said the policy targets malpractice in the sector.